Rapid Acting Antidepressants: Advances in Pharmacology, cartea 89
Ronald S. Duman, John H. Krystalen Limba Engleză Hardback – 25 iun 2020
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Din seria Advances in Pharmacology
- 25%
Preț: 1068.91 lei - 5%
Preț: 542.15 lei - 5%
Preț: 551.83 lei - 5%
Preț: 543.41 lei - 23%
Preț: 438.81 lei - 5%
Preț: 560.62 lei - 5%
Preț: 1923.04 lei - 5%
Preț: 1922.16 lei - 5%
Preț: 1930.54 lei - 29%
Preț: 1004.67 lei - 29%
Preț: 1131.29 lei - 27%
Preț: 1486.29 lei - 27%
Preț: 1480.25 lei - 5%
Preț: 1827.70 lei - 5%
Preț: 1837.16 lei - 5%
Preț: 1825.12 lei - 5%
Preț: 1826.93 lei - 5%
Preț: 1830.95 lei - 5%
Preț: 1841.19 lei - 29%
Preț: 1073.49 lei - 29%
Preț: 1079.06 lei - 32%
Preț: 1026.57 lei - 29%
Preț: 1078.00 lei - 29%
Preț: 1075.75 lei - 32%
Preț: 1030.88 lei - 9%
Preț: 1032.61 lei - 29%
Preț: 1072.97 lei - 29%
Preț: 1078.38 lei - 29%
Preț: 1074.03 lei - 29%
Preț: 1073.22 lei - 25%
Preț: 1070.78 lei - 29%
Preț: 1071.06 lei - 29%
Preț: 1071.78 lei - 24%
Preț: 1150.43 lei - 24%
Preț: 1149.55 lei - 25%
Preț: 1072.05 lei - 15%
Preț: 1209.67 lei - 15%
Preț: 1215.63 lei - 25%
Preț: 1075.40 lei - 25%
Preț: 1074.41 lei - 25%
Preț: 1074.83 lei - 25%
Preț: 1073.42 lei
Preț: 1151.52 lei
Preț vechi: 1679.92 lei
-31% Nou
Puncte Express: 1727
Preț estimativ în valută:
220.40€ • 229.23$ • 184.70£
220.40€ • 229.23$ • 184.70£
Carte tipărită la comandă
Livrare economică 07-21 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128201893
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
Public țintă
investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.Cuprins
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmissionAllie J. Widman and Lori L. McMahon
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibitionBernhard Luscher, Mengyang Feng and Sarah J. Jefferson
- The role of eEF2 kinase in the rapid antidepressant actions of ketamineKanzo Suzuki and Lisa M. Monteggia
Part II – The rapid therapeutic effects of ketamine - Clinical overview of NMDA-R antagonists and clinical practicePasha A. Davoudian and Samuel T. Wilkinson
- Ketamine for depression clinical issuesSyed Z. Iqbal and Sanjay J. Mathew
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidenceLynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
- Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressantsJaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
- The emergence of ketamine as a novel treatment for posttraumatic stress disorderAdriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III – Novel rapid-acting antidepressant mechanisms related to ketamine - mGlu2/3 receptor as a novel target for rapid acting antidepressantsShigeyuki Chaki
- Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions